Low cost diabetes breath analyzer based on nanostructured K.SUB.2.W.SUB.7.O.SUB.22 .material
11672440 · 2023-06-13
Assignee
Inventors
Cpc classification
A61B5/097
HUMAN NECESSITIES
A61B5/7282
HUMAN NECESSITIES
A61B5/082
HUMAN NECESSITIES
A61B5/4836
HUMAN NECESSITIES
A61B2090/064
HUMAN NECESSITIES
International classification
A61B5/08
HUMAN NECESSITIES
A61B5/00
HUMAN NECESSITIES
A61B90/00
HUMAN NECESSITIES
G01N27/12
PHYSICS
Abstract
Disclosed herein is a device detecting volatile organic compounds, such as acetone, using nanostructured K.sub.2W.sub.7O.sub.22 crystals. Methods for detecting a subject in a state of ketosis, such as diabetes, using a volatile organic sensing device are disclosed. A method for synthesizing K.sub.2W.sub.7O.sub.22 nanostructured sensing crystals is further disclosed.
Claims
1. A device for detecting Volatile Organic Compounds (VOCs) at room temperature and below 100° C., comprising: (a) a VOC sensor comprised of (i) a pair of electrodes, (ii) a moisture sensor, and (iii) nanostructured K.sub.2W.sub.7O.sub.22 extending between the pair of electrodes; (b) a pressure sensor; and (c) a microprocessor operably connected to the VOC sensor and configured to calculate a concentration of a VOC based, at least in part, on a resistance change of the nanostructured K.sub.2W.sub.7O.sub.22 caused by adsorption of the VOC to the nanostructured K.sub.2W.sub.7O.sub.22.
2. The device of claim 1 wherein the VOC sensor is an acetone sensor.
3. The device of claim 1, wherein the device further includes an electric fan.
4. The device of claim 1, wherein the device further includes a desiccant placed within or connected to the device.
5. The device of claim 2, wherein the device further includes an electric fan.
6. The device of claim 2, wherein the device further includes a desiccant placed within or connected to the device.
7. A method of diagnosing a subject as in a state of ketosis comprising: (a) having a subject breathe into a device according to claim 1, to determine an acetone concentration; and (b) diagnosing the subject as in a state of ketosis if the acetone concentration is greater than or equal to 1.7 ppm acetone.
8. The method of claim 7, wherein the state of ketosis is selected from ketogenic diet, lung cancer, alcoholism, alcoholic binge drinking, diabetes, fasting, weight loss, or combinations thereof.
9. The method of claim 8, wherein the state of ketosis is diabetes.
10. The method of claim 7, wherein the method is performed at ambient temperature.
11. The method of claim 10 and further comprising administering treatment to the diagnosed subject.
12. A method of detecting VOCs in the breath of a subject comprising: (a) having a subject breathe into a device according to claim 1; and (b) computing the ppm of the VOC in the subject's breath.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The presently-disclosed subject matter will be better understood, and features, aspects and advantages other than those set forth above will become apparent when consideration is given to the following detailed description thereof. Such detailed description makes reference to the following drawings, wherein:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25) While the disclosure is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described below in detail. It should be understood, however, that the description of specific embodiments is not intended to limit the disclosure to cover all modifications, equivalents and alternatives falling within the spirit and scope of the disclosure as defined by the appended claims.
DESCRIPTION OF EXEMPLARY EMBODIMENTS
Definitions
(26) The details of one or more embodiments of the presently-disclosed subject matter are set forth in this document. Modifications to embodiments described in this document, and other embodiments, will be evident to those of ordinary skill in the art after a study of the information provided in this document. The information provided in this document, and particularly the specific details of the described exemplary embodiments, is provided primarily for clearness of understanding and no unnecessary limitations are to be understood therefrom. In case of conflict, the specification of this document, including definitions, will control.
(27) While the terms used herein are believed to be well understood by those of ordinary skill in the art, certain definitions are set forth to facilitate explanation of the presently-disclosed subject matter.
(28) Unless defined otherwise, all technical and scientific terms used herein have the same meaning as is commonly understood by one of skill in the art to which the invention(s) belong.
(29) All patents, patent applications, published applications and publications, GenBank sequences, databases, websites and other published materials referred to throughout the entire disclosure herein, unless noted otherwise, are incorporated by reference in their entirety.
(30) Where reference is made to a URL or other such identifier or address, it understood that such identifiers can change and particular information on the internet can come and go, but equivalent information can be found by searching the internet. Reference thereto evidences the availability and public dissemination of such information.
(31) As used herein, the abbreviations for any protective groups, amino acids and other compounds, are, unless indicated otherwise, in accord with their common usage, recognized abbreviations, or the IUPAC-IUB Commission on Biochemical Nomenclature (see, Biochem. (1972) 11(9):1726-1732).
(32) Although any methods, devices, and materials similar or equivalent to those described herein can be used in the practice or testing of the presently-disclosed subject matter, representative methods, devices, and materials are described herein.
(33) Following long-standing patent law convention, the terms “a”, “an”, and “the” refer to “one or more” when used in this application, including the claims. Thus, for example, reference to “a device” includes a plurality of such devices, and so forth.
(34) Unless otherwise indicated, all numbers expressing quantities of ingredients, properties such as reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about”. Accordingly, unless indicated to the contrary, the numerical parameters set forth in this specification and claims are approximations that can vary depending upon the desired properties sought to be obtained by the presently-disclosed subject matter.
(35) As used herein, the term “about,” when referring to a value or to an amount of mass, weight, time, volume, concentration or percentage is meant to encompass variations of in some embodiments ±10%, in some embodiments ±5%, in some embodiments ±1%, in some embodiments ±0.5%, in some embodiments ±0.1%, and in some embodiments ±0.01% from the specified amount, as such variations are appropriate to perform the disclosed method.
(36) As used herein, ranges can be expressed as from “about” one particular value, and/or to “about” another particular value. It is also understood that there are a number of values disclosed herein, and that each value is also herein disclosed as “about” that particular value in addition to the value itself. For example, if the value “10” is disclosed, then “about 10” is also disclosed. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.
(37) As used herein, “optional” or “optionally” means that the subsequently described event or circumstance does or does not occur and that the description includes instances where said event or circumstance occurs and instances where it does not. For example, an optionally variant portion means that the portion is variant or non-variant.
(38) As used herein, the term “subject” refers to a target in need of a diagnosis. The subject of the herein disclosed methods can be a mammal. Thus, the subject of the herein disclosed methods can be a human, non-human primate, horse, pig, rabbit, dog, sheep, goat, cow, cat, guinea pig or rodent. The term does not denote a particular age or sex. Thus, adult and newborn subjects, whether male or female, are intended to be covered. A “patient” refers to a subject afflicted with a disease or disorder. The term “patient” includes human and veterinary subjects.
(39) As used herein, the term “diagnosed” means having been subjected to a physical examination by a person of skill, for example, a physician, and found to have a condition that can be diagnosed or treated by the compounds, compositions, or methods disclosed herein. Such a diagnosis can be in reference to a disorder, such as diabetes, and the like, as discussed herein.
(40) As used herein the term “ambient temperature” comprises typical temperatures living subjects are exposed to. Ambient temperatures range from approximately 0° C. to 550° C.
(41) As used herein, the term “diabetes” can refer to Type I or Type II diabetes unless otherwise specified.
(42) As used herein the term “state of ketosis” refers to a metabolic state of a subject where the body has insufficient access to glucose and is producing ketone bodies for energy from lipid stores. A subject may be in a state of ketosis for several reasons, some of these reasons, which are appreciated in the art, include consuming a ketogenic diet, lung cancer, alcoholism, alcoholic binge drinking, diabetes, fasting, and weight loss.
Embodiments
(43) One embodiment of the present invention is a volatile organic compound (VOC) sensing device comprising: a volatile organic compound sensor component; a pressure sensor; and a microprocessor.
(44) In a further embodiment of the present invention, the VOC sensor component is comprised of: a pair of electrodes; a moisture sensor; and nanostructured K.sub.2W.sub.7O.sub.22.
(45) In another embodiment of the present invention, the microprocessor collects moisture data, reads an acetone signal, calculates VOC concentration, generates electromagnetic signals, and displays the concentration of acetone in the sample in ppm.
(46) In some embodiments of the present invention the VOC is acetone.
(47) In a further embodiment of the present invention, the device includes an electric fan to refresh the air within the device.
(48) In another embodiment of the present invention, a desiccant is placed in or connected to the device.
(49) In one embodiment, the present invention relates to a method for diagnosing a subject as in a state of ketosis.
(50) In another embodiment, the present invention further relates to diagnosing a subject as in a state of ketosis comprising having a subject breathe into a device comprising: an acetone sensor, a pressure sensor, and a microprocessor.
(51) In various embodiments of the present invention, the state of ketosis is selected from a ketogenic diet, lung cancer, alcoholism, alcoholic binge drinking, diabetes, fasting, weight loss, or combinations thereof.
(52) In some embodiments of the present invention, the state of ketosis is type I or type II diabetes.
(53) A further embodiment of the present invention is a method for diagnosing a subject as having diabetes comprising having a subject breathe into a device comprising: an acetone sensor, a pressure sensor, and a microprocessor, and diagnosing the subject with diabetes when the acetone concentration is greater than or equal to about 1.7 ppm.
(54) Another embodiment of the present invention includes a method of making K.sub.2W.sub.7O.sub.22 nanocrystals comprising: making a solution comprising: Na.sub.2WO.sub.4, Oxalic acid, K.sub.2SO.sub.4, HCl, autoclaving the solution; and growing crystals at 160, 180, 210, or 225° C. for about 24 hours.
EXAMPLES
(55) Materials & Methods
Example 1: Material Synthesis
(56) The nanostructured K.sub.2W.sub.7O.sub.22 was synthesized with a hydrothermal method [17-19]. It uses a precursor solution containing Na.sub.2WO.sub.4, oxalic acid, K.sub.2SO.sub.4, and HCl. The composition of this material has been analyzed with XPS, revealing that the atom ratio of K:W:O is 2:7:22. Further study demonstrated that the geometric structure of the nanorods could be tuned by varying the temperature for hydrothermal growth; higher temperature led to longer nanorods with better crystallinity (
Example 2: Characterization of Acetone Sensing Performance
(57) The acetone sensing performance of the materials optimized based on the investigation of the ferroelectric property and the simulation of acetone molecule adsorption on different exposed facets have been characterized with a programmable chemiresistive gas sensor measurement system (
Example 3: A New Material, Nanostructured K.SUB.2.W.SUB.7.O.SUB.22 .has been Developed
(58) The performance of the nanostructured K.sub.2W.sub.7O.sub.22 for sensing acetone has been studied by varying the acetone concentration from 0 ppm (i.e., no acetone) to 50 ppm, where the acetone was carried by air at a relative humidity (RH) of ˜30%. It was shown that (1) the resistance of sensing film changes upon acetone adsorption, (2) the resistance change is greater when the acetone concentration is higher, and (3) there is no difficulty in sensing acetone with a concentration as low as 2.0 ppm (
Example 4: The Semiconducting Property of the K.SUB.2.W.SUB.7.O.SUB.22 .was Studied Using the Hall Effect Technique
(59) It showed that K.sub.2W.sub.7O.sub.22 is a p-type semiconductor and the carrier concentration and mobility are 3.26×10.sup.17 cm.sup.−3 and 7.5×10.sup.−2 cm.sup.2V.sup.−1 s.sup.−1, respectively. A semiconductor that is p-type means that its majority carriers are holes. This can explain why the resistance increases upon the adsorption of acetone molecules in
Example 5: KWO Synthesis and Imaging
(60) The single crystalline nanostructured KWO was synthesized by a hydrothermal technique [17,61]. Briefly, a precursor solution containing Na.sub.2WO.sub.4, oxalic acid, K.sub.2SO.sub.4, and HCL is made. This solution is then put into a 30 mL autoclave for synthesis. KWO samples were grown at 225° C. for 24 hours. The as-synthesized nanostructured KWO were dispersed in ethanol to form a suspension and drop-casted on glass substrates to form a thin film with about 10 μm in thickness. The morphology of the KWO film was studied with scanning electron microscopy (SEM) (
(61)
Example 6: Circuit Design
(62) To detect the signal, a cost-efficient circuit was made with available components such as resistors, potentiometers, LM741 CNNS op-amp [43], and 9V battery. The printed circuit board (PCB) was designed from OSHPARK [44]. As shown in FIG. 10, 10 MΩ and 50 MΩ resistors were connected with SPDT switch [45] for compatible adjustment with the sensor resistance while testing different ranges of acetone concentration. The other branch of the Wheatstone bridge was introduced with a potentiometer to make zero correction of the circuit. Buffer amplifiers [46] were introduced in the circuit to avoid impedance problem and to get unity gain. Because the signal from sensor detection is weak, a differential amplifier was used to amplify the signal. The voltages were taken from the two branches of the Wheatstone bridge. The amplification ratio was set up in accordance with the range of acetone detection. For instance, to detect low concentration of acetone (0-5) ppm, the signal was amplified 10 times.
Example 7: Experimental Design
(63) The sensor was tested with 0-6.25 ppm and 0-50 ppm concentration of acetone. The primary goal was to check the sensitivity of the circuit while the concentration of acetone is low (0-6.25 ppm). The other goal was to make sure that the circuit can functionally work nicely in a broad range of acetone concentration, 0-50 ppm.
Example 8: Sensing Mechanism
(64) The KWO sensor is sensitive to acetone gas.
Example 9: Sensitivity
(65) Sensitivity is the most important parameters for evaluating the sensing performance of sensors [51]. Sensitivity is defined as the variation in current ratio for specific gas concentration. If I.sub.gas and I.sub.air are the current values of the sensor, then the sensitivity, S [26] is:
(66)
(67) Sensitivity can be also measured in terms of voltage [52] and resistance [53]. Two sets of data was collected from the testing system.
(68) TABLE-US-00004 TABLE 4 Sensitivity comparison between improved circuit measurement system (sample 1) and previous resistance measurement system (sample 2) for acetone concentrations of 0-6.25 ppm. Acetone Sample 1 Sample 2 Concentration (Sensitivity, (Sensitivity, (ppm) ΔV/Vo) × 100% ΔR/Ro) × 100% 0 0 0 1 4.411 0.1 2 9.823 0.2 3 14.117 0.225 4 17.588 0.245 5 18.882 0.28 6.25 22.647 0.29
Example 10: Sensing Performance
(69) The sensing performance of the KWO sensor was compared to low concentrations of acetone, 0-6.25 ppm, with and without using improved circuits as the signal collection. Table 4 shows the detection limit and sensitivity while the KWO sensor system employed the optimized detecting circuit. For example, the sensitivity of 1.0 ppm of acetone with the improved circuit was 441.1%, while the sensitivity without the improved circuit at 1.0 ppm of acetone was only 10%. The results indicated that the improved circuit significantly improved the sensitivity and detection limit of the KWO sensor. This is a very important improvement, in particular, considering the KWO sensor in application for the purpose of early stage type-1 diabetes diagnosis.
Example 11: The Voltage Change for the Acetone Concentration from 0 to 50 ppm was Also Measured
(70)
Example 12: Sensing Response Comparison with Pt—InN
(71) In
Example 13: KWO Synthesis Methods
(72) KWO is grown using the hydrothermal method. [19, 20] A precursor solution containing Na.sub.2WO.sub.4.2H.sub.2O (95%, Alfa Aesar), oxalic acid dihydrate (>99%, VWR), K.sub.2SO.sub.4 (>99%, VWR), and HCl (36-38%, Aqua Solutions Inc.) was made. This solution was then put into a 30 mL autoclave for synthesis. KWO samples were grown at 160, 180, 210, and 225° C. for 24 hours. Samples used for acetone sensing tests were applied to a sensor slide by blade coating and then annealed at 350° C.
Example 14: X-Ray Diffraction Spectrum (XRD)
(73) X-ray diffraction was obtained using a Bruker AXS D8 Discover to study as-synthesized KWO crystalline structure. Samples were made by coating a paste made from KWO and ethanol on glass substrates. A diffraction pattern was gathered from a 2-Theta of 5° to 90° C.
(74)
(75) TABLE-US-00005 TABLE 5 XPS Data of as-synthesized KWO. PEAK HEIGHT FWHM AREA (P) (BE) (CPS) (EV) (CPS.EV) ATOMIC % W.sub.4F 36.36 421721.42 4.08 1798872.21 23.41 O.sub.1S 530.34 334091.36 2.59 995253.52 68.46 K.sub.2P 293.29 38855.81 2.70 168932.44 6.05
Example 15: Transmission Electron Microscopy (TEM)
(76) TEM imaging was obtained using a JEOL JEM-2100 high-resolution analytical TEM. Samples were prepared on carbon grids by sonication.
(77) TABLE-US-00006 TABLE 6 Lattice fringe spacing for samples grown at 160, 180, 210, and 225° C. Growth Temperature a-spacing c-spacing (° C.) (Å) (Å) 160 6.038 3.598 180 6.320 3.636 210 6.356 3.634 225 6.388 3.542
Example 16: FT-IR Spectrum
(78) The FT-IR used in this study was a Thermo Scientific Nicolet 8700 FT-IR spectrometer. It was used to find if there was a change in the surface functionalization of the KWO samples grown at different temperatures. Further structural and functional groups of KWO grown at 160° C. and 225° C. were studied using FT-IR, see
Example 17: Raman Spectroscopy
(79) Raman spectra were obtained using an Aramis Confocal Raman Imaging System with Horiba Jobin Yvon's Raman Spectrometer. It has been demonstrated previously that KWO has the ferroelectric property using a piezoresponse force microscope. [41] Raman spectroscopy was used to further study the ferroelectric property of KWO in this study. Previous reports have found that WO.sub.3 exhibits this property in a bulk phase called ε-WO.sub.3 which is only stable below −40° C. [24] However, it has also been found that ε-WO.sub.3 can exist at room temperature as microcrystals in a bulk sample.[59] Raman has been utilized in other studies to better understand the effect that doping has on the crystal phase WO.sub.3 expresses, and study the material's ferroelectric property. [27] Here, Raman spectroscopy was used to find peaks at room temperature, which can provide evidence of the existence of ε-WO.sub.3 within the KWO crystal phase at room temperature.
Example 18: Sensing Tests
(80) The acetone sensing performance has been done through a programmable chemiresistive gas sensor measurement system, which has been described elsewhere. [41, 54] Briefly, the acetone vapor is generated from OVG-4 (Owlstone, InC.) based on the theory of permeation tube. The concentration of acetone can be precisely controlled from 0 to 5 ppm. 50 ppm acetone is generated from acetone tank in dry nitrogen calibrated and made by Airgas, Inc. Once the acetone is exposure onto KWO film, a resistant change can be detected and recorded through an advanced circuit of signal collecting system. The sensing tests based on the as-synthesized KWO grown at different temperature to 50 ppm of acetone have been done and the results are shown in
[(R−R.sub.o)/R.sub.o]×100%=sensitivity. Equation (1):
(81) Based on this equation, the sensitivity for KWO grown at 160, 180, 210, and 225° C. was calculated and shown in
REFERENCES
(82) Each of the following references is herein incorporated by reference in their entirety. [1] International Diabetes Federation (IDF), Diabetes Atlas third Ed., Brussels, 2006. [2] National Diabetes Statistics Report, 2017. Available: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. [3] Y. Qiao, Z. Gao, Y. Liu, Y. Cheng, M. Yu, L. Zhao, Y. Duan, and Y. Liu. (2014, May). Breath Ketone Testing: A New Biomarker for Diagnosis and Therapeutic Monitoring of Diabetic Ketosis. BioMed. Research International, [Online], 2014(2014), pp. 1-5. Available: https://www.hindawi.com/journals/bmri/2014/869186/[4] [4] Non-invasive substance concentration measurement using an optical bridge, by S. Harjunmaa, R. A. Peura, and J. A. Rolls (2002, Apr. 26). U.S. Pat. No. 7,003,337 B2. [5] W. F. March, A. Muller, and P. Herbrechtsmeier, “Clinical trial of a noninvasive contact lens glucose sensor,” Diabetes Technology & Therapeutics, 2004, pp. 782-789. [6] A. E. Johannessen, B. Hinderling, C. Pugin, R. Mills, and G. Christiansen, “Injectable Osmotic Glucose Sensor and the Development of a Nanoporous Semi-permeable Membrane.” Diabetes Technology Meeting, 2005, San Francisco: Diabetes Technology Society. [7] H. T. Brown, M. N. Ediger, C. M. Fleming, E. L. Hull and M. Rohrscheib, “Clinical assessment of near infrared spectroscopy for noninvasive diabetes screening.” Diabetes Technology & Therapeutics, 2005, pp. 456-466. [8] R. Pandey, S. K. Paidi, T. A. Valdez, C. Zhang, N. Spegazzini, R. R. Dasari, and I. Barman. (2017, January). Noninvasive Measurements of Blood Glucose with Raman Spectroscopy. Accounts of Chemical Research. [Online] 50(2), pp. 2564-2′72, 2017. Available: http://pubs.acs.org/doi/ipdf/10.1021/acs.accounts.6b004726. [9] C. Inc. (2002, August). Glucowatch G2: Automatic Glucose Biographer and Auto-sensors. Redwood City, Calif. [Online]. Available: https://www.accessdata.fda.gov/cdrh_docs/pdf/P990026S008b.pdf [10] B. J. Novak, “Non-invasive monitoring of metabolism, diabetes and oxidative stress using exhaled human breath.” Ph.D. dissertation, Dept. Chem., Univ. of California, Irvine, 2007. [11] W. Miekisch, J. K. Schubert, and G. F. Noeldge-Schomburg. (2004, September). Diagnostic potential of breath analysis—focus on volatile organic compounds. Clinica Chimica Acta. [Online]. 347(1-2), pp. 25-39. Available: http://www.sciencedirect.com/science/article/pii/S0009898104002256 [12] A. Amann, P. Spanel, and D. Smith. (2007, February). Breath analysis: the approach towards clinical applications. Mini-reviews in medicinal chemistry, 7(2), pp. 115-129. [13] M. Shirasu and K. Touhara. (2011, September). The scent of disease: volatile organic compounds of the human body related to disease and disorder. Journal of biochemistry. [Online]. 150(3), pp. 257-266. Available: https://academic.oup.com/jb/article/150/3/257/867730/The-scent-of-disease-volatile-organic-compounds-of [14] G. Pennazza, M. Santonico, E. Martinelli, A. D'Amico, and C. Di Natale, “Interpretation of exhaled volatile organic compounds,” European respiratory monograph: exhaled biomarkers, 49, ERS., UK, 2010, pp. 115-129. [15] C. Wang, A. Mbi, and M. Shepherd. (2010, January). A study on breath acetone in diabetic patients using a cavity ringdown breath analyzer: Exploring correlations of breath actone with blood glucose and glycohemoglobinale. IEEE Sensors Journal, [Online], 10(1), pp. 54-63. Available: http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=5350908 [16] C. Deng, J. Zhang, X. Yu, W. Zhang, and X. Zhang. (2004, October). Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. Journal of Chromatography B, [Online], 810(2), pp. 269-275. Available: http://www.sciencedirect.com/science/article/pii/S1570023204006579?via %3Dihub [17] M. Yoshimura and K. Byrappa. (2008, April). Hydrothermal processing of materials: past, present and future. J. Mater. Sci., [Online] 43(7), pp. 2085-2103. Available: https://link.springer.com/article/10.1007/s10853-007-1853-x [18] J. Jitputti, S. Pavasupree, Y. Suzuki, and S. Yoshikawa. (2008, January). Synthesis of TiO.sub.2 nanotubes and its photocatalytic activity for H.sub.2 evolution. Japanese Journal of Applied Physics, [Online], 47(1), pp. 751-756. Available: http://iopscience.iop.org/article/10.1143/JJAP.47.751/pdf [19] S. Supothina, M. Suwan, and A. Wisitsoraat. (2014, August). Hydrothermal synthesis of K.sub.2W.sub.4O.sub.13 nanowire with high H.sub.2S gas sensivitity. Microelectronic Engineering. [Online]. 126, pp. 88-92. Available: http://www.sciencedirect.com/science/article/pii/S0167931714002676 [20] D. Wang and Q. Zhang, “Room temperature acetone sensor based on nanostructured K.sub.2W.sub.7O.sub.22.” Sensors, 2016 IEEE, 2016, [Online], pp. 1-3. Available: http://ieeexplore.ieee.org/document/7808635/[21] MR. Hossain, Q. Zhang, M. Johnson, and D. Wang. (2017, October). Investigation of humidity cross-interference effect on acetone breath sensor based on nanostructured K.sub.2W.sub.7O.sub.22. Engineering Press, [Online], 1(1), pp. 30-34. Available: http://onlinepublishingpress.com/engineering-press/article-in-press.php [22] C. H. Deng, J. Zhang, X. F. Yu, W. Zhang, and X. M. Zhang. (2004, October). Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. Journal of Chromatography B, [Online], 810(2), pp:269-275. Available: http://www.sciencedirect.com/science/article/pii/S1570023204006579 [23] M. X. Sun, Z. Y. Chen, Z. Y. Gong, X. M. Zhao, C. Y. Jiang, Y. Yuan, Z. Wang, Yi. Li, and C. Wang. (2015, February). Determination of breath acetone in 149 Type 2 diabetic patients using a ringdown breath-acetone analyzer. Analytical and Bioanalytical Chemistry, [Online] 407(6), pp. 1641-1650. Available: https://link.springer.com/article/10.1007%2Fs00216-014-8401-8 [24] M. Righettoni, A. Tricoli, and S. E. Pratsinis. (2010, May). Si:WO.sub.3 Sensors for Highly Selective Detection of Acetone for Easy Diagnosis of Diabetes by Breath Analysis. Analytical Chemistry, [Online], 82(9), pp. 3581-3587. Available: http://pubs.acs.org/doi/pdf/10.1021/ac902695n [25] M. Righettoni, A. Tricoli, S. Gass, A. Schmid, A. Amann, and S. E. Pratsinis. (2012, August). Breath acetone monitoring by portable Si:WO.sub.3 gas sensors. Analytica chimica acta, [Online] 738, pp. 69-75. Available: http://www.sciencedirect.com/science/article/pii/S0003267012008276?via %3Dihub [26] K. W. Kao, M. C. Hsu, Y. H. Chang, S. Gwo, and J. A. Yeh. (2012, May). A Sub-ppm Acetone Gas Sensor for Diabetes Detection Using 10 nm Thick Ultrathin InN FETs. Sensors, [Online], 12(6), pp. 7157-7168. Available: http://www.mdpi.com/1424-8220/12/6/7157/htm [27] L. Wang, A. Teleki, S. E. Pratsinis, and P. I. Gouma. (2008, July). Ferroelectric WO.sub.3 nanoparticles for acetone selective detection. Chemistry of Materials, [Online], 20(15), pp. 4794-4796. Available: http://pubs.acs.org/doi/pdfplus/10.1021/cm800761e [28] L. Wang, K. Kalyanasundaram, M. Stanacevic, and P. Gouma. (2010, October). Nanosensor Device for Breath Acetone Detection. Sensor Letters, [Online]. 8(1-4), pp. 709-712. Available: http://www.ece.sunysb.edu/˜milutin/pubs/journal/gasSensorSL10.pdf [29] A. Vomiero, S. Bianchi, E. Comini, G. Faglia, M. Ferroni, and G. Sberveglieri. (2007, December). Controlled growth and sensing properties of In.sub.2O.sub.3 nanowires. Crystal Growth & Design. [Online]. 7(12), pp. 2500-2504. Available: http://pubs.acs.org/doi/pdf/10.1021/cg070209p [30] N. Kakati, S. H. Jee, S. H. Kim, J. Y. Oh, and Y. S. Yoon. (2010, October). Thickness dependency of sol-gel derived ZnO thin films on gas sensing behaviors. Thin Solid Films, [Online], 519(1), pp. 494-498. Available: http://www.sciencedirect.com/science/article/pii/S0040609010011193 [31] P. A. Murade, V. S. Sangawar, G. N. Chaudhari, V. D. Kapse, and A. U. Bajpeyee. (2011, May). Acetone gas-sensing performance of Sr-doped nanostructured LaFeO.sub.3 semiconductor prepared by citrate sol-gel route. Current Applied Physics, [Online], 11(3), pp. 451-456. Available: http://www.sciencedirect.com/science/article/pii/S1567173910002749 [32] A. Teleki, S. E. Pratsinis, K. Kalyanasundaram, and P. I. Gouma. (2006, December). Sensing of organic vapors by flame-made TiO.sub.2 nanoparticles. Sensors and Actuators B—Chemical, [Online], 119(2), pp. 683-690. Available: http://www.sciencedirect.com/science/article/pii/S0925400506000475 [33] F. Qu, J. Liu, Y. Wang, S. Wen, Y. Chen, X. Li, and S. Ruan. (2014, August). Hierarchical Fe.sub.3O.sub.4@Co.sub.3O.sub.4 core-shell microspheres: Preparation and acetone sensing properties. Sensors and Actuators B—Chemical, [Online], 199, pp. 346-353. Available: http://www.sciencedirect.com/science/article/pii/S0925400514004031 [34] H. Ahn, Y. Wang, S. H. Jee, M. Park, Y. S. Yoon, and D.-J. Kim. (2011, August). Enhanced UV activation of electrochemically doped Ni in ZnO nanorods for room temperature acetone sensing. Chemical Physics Letters, [Online], 511(4-6), pp. 331-335. Available: http://www.sciencedirect.com/science/article/pii/S000926141100755X [35] Artur Rydosz, A Negative Correlation Between Blood Glucose and Acetone Measured in Healthy and Type 1 Diabetes Mellitus Patient Breath, J Diabetes Sci Technol 2015, 9, 881-884, doi: 10.1177/1932296815572366 [36] H. Jamalabadi and N. Alizadeh, IEEE Sens. 1, 2017, 17, 2322-2328 [37] K. W. Kao, M. C. Hsu, Y. H. Chang, S. Gwo and J. A. Yeh, Sensors, 2012, 12, 7157-7168. [38] A. Hazra, B. Bhowmik, K. Dutta and P. Bhattacharyya. Presented in Seventh International Conference on Sensing Technology (ICST), IEEE, Wellington, New Zealand, 3-5 Dec. 2013. [39] D. Subhashis, A. Bag, R. Kumar and D. Biswas, IEEE-EDL, 2017, 38, 383-386 [40] Chemiresistors, http://www.sandia.gov/mstc/_assets/documents/Fact_Sheets/sensors/2chemiresistor.pdf, (accessed 7 Apr. 2018) [41] D. Wang, Q. Zhang, M. R. Hossain and M. Johnson, IEEE Sens. J., 2018, 18, 4399-4404. [42] N. Barsan and U. Weimar, J. of Electroc., 2001, 7, 143-167 [43] Dipole moment, https://en.wikipedia.org/wiki/Dipole_moment (3Apr. 2018) [44] B. Caveman (2014, March). Ketonix Review. [Online]. Available: bjjcaveman.com/2014/03/15/ketonix-review/[45] [45] T. Soper (2013, November). This handheld device helps you lose weight by detecting acetone levels in your breath. [Online]. Available: www.geekwire.com/2013/small-device-detects-acetone-levels-breath-measure-fat-burning/[46] [46] C. A. Newton, P. Raskin, Arch Intern Med., 2004, 164: 1925-1931. [47] J. C. Anderson. Obesity, 2015, 23: 2327-2334. [48] L. C. McGuire, A. M Cruickshank, P. T. Munro, Emerg. Med. J. 2006, 23: 417-420. [49] Electrostatic Interactions. Available online: https://www.sciencedirect.com/topics/chemistry/electrostaticinteractions (accessed on 1 Sep. 2018). [50] Fine, G. F.; Cavanagh, L. M.; Afonja, A.; Binions, R. Metal Oxide Semi-Conductor Gas Sensors in Environmental Monitoring. Sensors 2010, 10, 5469-5502. [CrossRef] [PubMed]. [51] Chemical Sensors. Available online: https://www.nap.edu/read/4782/chapter/10#74 (accessed on 15 Oct. 2018). [52] Sensor. Available online: https://en.wikipedia.org/wiki/Sensor (accessed on 15 Oct. 2018). [53] Kargar, A. Sensitivity Analysis of Silicon Nanowire Chemical Sensor. In Proceedings of the 8th IEEE Conference on Nanotechnology, Arlington, Tex., USA, 18-21 Aug. 2008. [54] MR Hossain, Q Zhang, M Johnson, D Wang (2018) Highly Sensitive Room-Temperature Sensor Based on Nanostructured K.sub.2W.sub.7O.sub.22 for Application in the Non-Invasive Diagnosis of Diabetes. Sensors 18(11): 3703-3712. [55] Buszewski, B., Kesy, M., Ligor, T., & Amann, A. (2007). Human exhaled air analytics: Biomarkers of diseases. Biomedical Chromatography, 21(6), 553-566. doi:10.1002/bmc.835. [56] Konvalina, G., & Haick, H. (2014). Sensors for Breath Testing: From Nanomaterials to Comprehensive Disease Detection. Accounts of Chemical Research, 47(1), 66-76. doi:10.1021/ar400070m. [57] Jia, Q. Q., Ji, H. M., Wang, D. H., Bai, X., Sun, X. H., & Jin, Z. G. (2014). Exposed facets induced enhanced acetone selective sensing property of nanostructured tungsten oxide. Journal of Materials Chemistry A, 2(33), 13602-13611. doi:10.1039/c4ta01930j. [58] Tang, B. L., Jiang, G. H., Chen, W. X., & Wan, J. M. (2015). First-Principles Study on Hexagonal WO.sub.3 for HCHO Gas Sensing Application. Acta Metallurgica Sinica-English Letters, 28(6), 772-780. doi:10.1007/s40195-015-0260-6. [59] Woodward, P. M., Sleight, A. W., & Vogt, T. (1997). Ferroelectric tungsten trioxide. Journal of Solid State Chemistry, 131(1), 9-17. doi:10.1006/jssc.1997.7268. [60] Arai, M., Hayashi, S., Yamamoto, K., & Kim, S. S. (1990). RAMAN STUDIES OF PHASE-TRANSITIONS IN GAS-EVAPORATED WO.sub.3 MICROCRYSTALS. Solid State Communications, 75(7), 613-616. doi:10.1016/0038-1098(90)90429-f. [61] Lopes, L. F., Pontes, F. M., Garcia, L. O., Pontes, D. S. L., Padovani, D., Chiquito, A. J., Longo, E. (2018). Silver-controlled evolution of morphological, structural, and optical properties of three dimensional hierarchical WO.sub.3 structures synthesized from hydrothermal method. Journal of Alloys and Compounds, 736, 143-151. doi:10.1016/j.jallcom.2017.11.095. [62] Li, T. T., Shen, Y. B., Zhao, S. K., Chen, X. X., Li, G. D., Lu, R., Shen, Y. S. (2018). Xanthate sensing properties of Pt-functionalized WO.sub.3 microspheres synthesized by one-pot hydrothermal method. Ceramics International, 44(5), 4814-4823. doi:10.1016/j.ceramint.2017.12.069. [63] Mu, W. J., Li, M., Li, X. L., Ma, Z. P., Zhang, R., Yu, Q. H., . . . Jian, Y. (2015). Guanidine sulfate assisted synthesis of hexagonal WO.sub.3 nanoparticles with enhanced adsorption properties. Dalton Transactions, 44(16), 7419-7427. doi:10.1039/c5dt00103j.
(83) It will be understood that various details of the presently disclosed subject matter can be changed without departing from the scope of the subject matter disclosed herein. Furthermore, the foregoing description is for the purpose of illustration only, and not for the purpose of limitation.